KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Edwards Lifesciences (EW) Profit After Tax (2016 - 2025)

Edwards Lifesciences (EW) has 17 years of Profit After Tax data on record, last reported at $81.9 million in Q4 2025.

  • For Q4 2025, Profit After Tax fell 78.96% year-over-year to $81.9 million; the TTM value through Dec 2025 reached $1.1 billion, down 74.61%, while the annual FY2025 figure was $1.1 billion, 74.61% down from the prior year.
  • Profit After Tax reached $81.9 million in Q4 2025 per EW's latest filing, down from $290.3 million in the prior quarter.
  • Across five years, Profit After Tax topped out at $3.1 billion in Q3 2024 and bottomed at $81.9 million in Q4 2025.
  • Average Profit After Tax over 5 years is $483.0 million, with a median of $353.7 million recorded in 2024.
  • Peak YoY movement for Profit After Tax: soared 699.95% in 2024, then tumbled 90.54% in 2025.
  • A 5-year view of Profit After Tax shows it stood at $335.3 million in 2021, then increased by 18.82% to $398.4 million in 2022, then fell by 7.2% to $369.7 million in 2023, then increased by 5.27% to $389.2 million in 2024, then tumbled by 78.96% to $81.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Profit After Tax were $81.9 million in Q4 2025, $290.3 million in Q3 2025, and $331.5 million in Q2 2025.